Jim Cramer Calls General Mills "Litmus Test for the Group"

General Mills, Inc. (NYSE:GIS) is one of the stocks on Jim Cramer’s game plan this week. Cramer noted the health habits of the younger generation affect the company, as he remarked:

“Now, lots of people have been wondering if the food stocks will ever catch a bid, and if they don’t after this, I don’t know what to say. We need to hear what General Mills is saying when it reports Wednesday morning. You want a litmus test for the group? What could be better than the maker of Cheerios, Lucky Charms, and Cinnamon Toast Crunch? With these, you alienate the Secretary of Health and Human Services. You’re taking fire from the GLP-1 weight loss drugs, and you run smack into a new generation of people in… their teens and early 20s who somehow, they’re committed to eating healthy.”

General Mills, Inc. (NYSE:GIS) provides branded foods, including cereals, snacks, meals, baking products, frozen items, ice cream, and pet food. During the November 11 episode, Cramer noted how GLP-1 drugs are affecting stocks like General Mills. He said:

“Sometimes when stocks are doing badly, I get worried, not because I want to get out, but because I wonder if I might be missing a once-in-a-generational bottom. Those don’t come around all that often, of course… Risk takers might want to consider General Mills, but only if you’re betting on a takeover because the food stocks are being eaten alive by those GLP-1 weight loss drugs.”

While we acknowledge the potential of GIS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.